(2E) -OBAA
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


(2E) -OBAA
Description:
(2E) -OBAA is a potent phospholipase A2 (PLA2) inhibitor, with an IC50 of 70 nM. (2E) -OBAA induces apoptosis of HUVEC cells. (2E) -OBAA blocks Melittin-induced Ca2+ influx in Trypanosoma brucei, with an IC50 of 0.4 μM[1][2][3][4].UNSPSC:
12352005Target:
Apoptosis; PhospholipaseType:
Reference compoundRelated Pathways:
Apoptosis; Metabolic Enzyme/ProteaseApplications:
COVID-19-immunoregulationField of Research:
Inflammation/ImmunologyAssay Protocol:
https://www.medchemexpress.com/2e-obaa.htmlSolubility:
10 mM in DMSOSmiles:
O=C (O) /C=C/C (C1=CC=C (CCCCCCCCCCCCCCCCCC) C=C1) =OMolecular Formula:
C28H44O3Molecular Weight:
428.66References & Citations:
[1]J Y Miao, et al. Inhibitors of phospholipase promote apoptosis of human endothelial cells. J Biochem. 1997 Mar;121 (3) :612-8.|[2]J Eintracht, et al. Calcium entry in Trypanosoma brucei is regulated by phospholipase A2 and arachidonic acid. Biochem J. 1998 Dec 15;336 (Pt 3) (Pt 3) :659-66.|[3]T Köhler, et al. Phospholipase A2 inhibition by alkylbenzoylacrylic acids. Biochem Pharmacol. 1992 Aug 18;44 (4) :805-13.|[4]Kethineedi VR, et al. Quantum dot-NBD-liposome luminescent probes for monitoring phospholipase A2 activity. Anal Bioanal Chem. 2013 Dec;405 (30) :9729-37.Shipping Conditions:
Room temperatureScientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
Phospholipase ACAS Number:
221632-26-4
